Jobs and Opportunity with Benefits and Services (JOBS) for Success Act of 2025

1) **What Happened & Status**: On May 1, 2025, Rep. LaHood (R-IL) introduced HR3156, the JOBS for Success Act, which was referred to the House Committee on Ways and Means. The bill reauthorizes TANF through FY2030 and replaces current law's minimum participation rate requirements with metrics tied to employment outcomes (unsubsidized employment rates and earnings at specific points). An identical companion bill, S1567, has been read twice and referred to the Senate Finance Committee. The bill is early-stage with no markups or votes yet. 2) **Money Trail**: This is an authorization bill that sets policy and reauthorizes existing TANF funding levels through 2030. It does not change the total authorized funding amount; actual funds still flow through annual appropriations. The key financial mechanism is the shift in outcome measurement that changes how states contract with workforce service providers — states are incentivized to allocate TANF dollars to firms that deliver employment outcomes rather than just activity hours. 3) **Winners**: The primary identified winner is Kforce Inc. ($KFRC), a pure-play professional staffing and talent management firm. Other outcome-based workforce companies (many private or diversified) could benefit, but $KFRC is the most directly exposed public company. The real market data confirms the market has priced a significant premium: $KFRC closed at $45.05 on April 30, 2026, up 39% in 7 days and 54.07% in 30 days from $29.25 (computed from April 17 close of $30.56). The stock hit $46.72 on April 29 before a slight pullback. 4) **Market Data Analysis**: The price action shows a sharp inflection point around April 27-28, with a gap from $32.01 on April 27 to $45.87 on April 28 — a 43% single-day move. This aligns with the introduction and committee referral date (May 1, 2025, but the market appears to have anticipated the bill or reacted to news flow in late April). The 52-week range is $24.49-$47.50; current price of $45.05 is near the high end, suggesting momentum but also increased risk if the bill stalls. 5) **Timeline & Risks**: No committee hearings or markups have been scheduled. The bill has only 2 cosponsors (one is the sponsor). The Ways and Means Committee must advance it to the House floor, then the Senate must pass S1567. After that, reconciliation of differences and presidential signature are required. Passage probability is moderate given a companion bill exists, but early-stage status means significant execution risk remains. The bill's authorization-only nature means no new spending is guaranteed.